This session will focus on the fundamentals required for the HF FDA regulatory requirements and how to continue to make progress despite challenges presented by COVID-19 and associated social distancing requirements. There are a number of key milestones that can be completed using remote testing methodologies that will successfully fulfill Human Factors requirements. Additionally, there are many key decisions and planning efforts businesses can conduct now to ensure they are able to hit the ground running once restrictions have been lifted, minimizing expensive delays and potential loss of market opportunities.